We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Benign Hematology

Journal Scan / Research · February 23, 2022

Validation of the Khorana Score for Predicting VTE in Cancer Patients Starting Chemotherapy

Blood Advances


Additional Info

Disclosure statements are available on the authors' profiles:

Blood Advances
Validation of the Khorana score for predicting venous thromboembolism in 40 218 cancer patients initiating chemotherapy
Blood Adv 2022 Jan 19;[EPub Ahead of Print], T Overvad, A Ording, PB Nielsen, F Skjøth, IE Albertsen, S Noble, A Krog Vistisen, IL Gade, MT Severinsen, G Piazza, TB Larsen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading